Search Results 1461-1470 of 19961 for Receptor

  1. A Study to Evaluate Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy for HER2+ Gastrointestinal Cancers - Mayo Clinic

    ... receptor 2 (HER2)+ gastrointestinal cancers. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  2. Tolerability, safety and deep response found in cevostamab phase 1 trial - Mayo Clinic

    Fonseca explains that options such as chimeric antigen receptor (CAR)-T cell therapy are available to such patients. But such an option involves removing T ...

  3. Pivoting toward a new strategy for fighting disease - Mayo Clinic News Network

    Chimeric antigen receptor therapy (CAR-T therapy) is an example of a biotherapeutic that is transforming care for some blood cancers. CAR-T therapy uses ...

  4. Safety and Efficacy Study of MLN0128 in Combination With Exemestane or Fulvestrant in Postmenopausal Women With ER/PR+ Metastatic Breast Cancer - Mayo Clinic

    ... receptor positive/human epidermal growth factor receptor 2 negative (ER+/HER2-) advanced or metastatic breast cancer that has progressed on treatment with ...

  5. Pharmacogenomics Program - Center for Individualized Medicine - Mayo Clinic Research

    A Prospective Study to Evaluate the Role of Tumor Sequencing in Women Receiving Palbociclib for Advanced Hormone Receptor (HR)-Positive Breast Cancer ...

  6. Caffeine: How does it affect blood pressure? - Mayo Clinic

    Adenosine, adenosine receptors and neurohumoral syncope: From molecular basis to personalized treatment. ... Angiotensin II receptor blockers · Angiotensin- ...

  7. Publications - Brian J. Burkett, M.D., M.P.H. - Mayo Clinic

    ... Receptor Radionuclide Therapy. Radiology. 2021 Feb; 298 (2):261-274 Epub 2020 Nov 24. View PubMed; Pashos NC, Graham DM, Burkett BJ, O'Donnell B, Sabol RA ...

  8. Women's Wellness: What do you know about having a breast biopsy?

    ... receptor positive or negative. You and your health care provider can then develop a treatment plan that best suits your needs. This article is written by ...

  9. Functional Dyspepsia Clinical Trials

    The purpose of this study is to analyze the effects of the NK1 receptor antagonist, tradipitant, on gastric function and symptom improvement in patients with ...

  10. Mayo Clinic launches neutralizing antibody test to advance COVID-19 therapies

    The surface of the SARS-CoV-2 virus is coated with the spike glycoprotein, which binds to receptor proteins on the surface of healthy cells, leading to ...